Thyroid recalled over manufacturing violations
- Recall date
- August 28, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Humco Holding Group, Inc recalls Thyroid, USP (Full Strength) Levothyroxine 112.1 mcg/grain Liothyronine 29.2 mcg/grain Active Pharmaceutical Ingredient…
- Recall number
- D-0024-2019
- FDA classification
- Class II
- Brand / firm
- Humco Holding Group, Inc
- Sold / distributed
- Nationwide.
Why it was recalled
CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Thyroid, USP (Full Strength) Levothyroxine 112.1 mcg/grain Liothyronine 29.2 mcg/grain Active Pharmaceutical Ingredient Rx Only 1000 grams NDC 0395-6580-43 Packaged by: Humco Texarkana, TX 75501 USA
Get recall alerts
Free email alert whenever Humco Holding Group, Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Humco Holding Group, Inc